US OptionsDetailed Quotes
GLUE241220P2500
- 0.02
- 0.000.00%
15min DelayClose Nov 25 16:00 ET
0.00High0.00Low
0.02Open0.02Pre Close0 Volume12 Open Interest2.50Strike Price0.00Turnover231.62%IV70.69%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.0096Delta0.0051Gamma423.00Leverage Ratio-0.0026Theta-0.0001Rho-4.05Eff Leverage0.0006Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet